Guggenheim’s $460 target on ELV

ELV Elevance Health

$421 → $460 (+9%) by Oct 2027

Buy · raises · said Oct 12, 2026 · 12-month default horizon

Open: judged on the close on Oct 12, 2027

The article this target came from

Guggenheim raises Elevance stock price target to $460 on earnings outlook

Investing.com · Oct 12, 2026

Guggenheim raises Elevance stock price target to $460 on earnings outlook

Guggenheim’s track record → Elevance Health →

A fact about what Guggenheim published, as reported by Investing.com, not a recommendation from Dalsna Finance; Guggenheim is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.